UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000024154 |
|---|---|
| Receipt number | R000027812 |
| Scientific Title | Phase II study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel therapy for patients with borderline resectable pancreatic cancer. |
| Date of disclosure of the study information | 2016/10/01 |
| Last modified on | 2023/10/01 13:19:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/09/25 11:03:07 | ||
| 2 | Update | 2016/09/27 21:02:35 | Institutions |
|
| 3 | Update | 2016/11/15 09:18:44 | Organization Organization Organization Division Nationality of Funding Organization Nationality of Funding Organization |
|
| 4 | Update | 2017/01/10 20:59:28 | Recruitment status |
|
| 5 | Update | 2017/07/01 17:27:12 | Recruitment status |
|
| 6 | Update | 2019/09/28 12:31:24 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 7 | Update | 2020/09/28 21:21:35 | Recruitment status Date of IRB Last follow-up date |
|
| 8 | Update | 2022/09/30 16:50:29 | URL releasing protocol Number of participants that the trial has enrolled |
|
| 9 | Update | 2023/04/01 10:42:31 | Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 10 | Update | 2023/10/01 13:19:45 | Recruitment status |
